Sodium glycididazole combined with definitive chemoradiotherapy for patients with esophageal squamous cell carcinoma: A multicenter randomized clinical trial

Documenti analoghi

• Neoadjuvant versus adjuvant chemoradiotherapy for resectable cT3‐4a esophageal squamous cell carcinoma: A matched cohort analysis
  di: Mingqiang Lin, et al.
  Pubblicazione: (2026)
• Long‐term survival after immunotherapy for uncontrolled locally advanced temporal bone squamous cell carcinoma followed by chemoradiotherapy: A case report
  di: Jin Yan, et al.
  Pubblicazione: (2024)
• Radiotherapy after Neoadjuvant Immunochemotherapy in Unresectable Stage III Non‐Small Cell Lung Carcinoma: A Novel Therapeutic Approach?
  di: Peizhu Wu, et al.
  Pubblicazione: (2025)
• MRI‐based qualitative, quantitative, and radiomics/deep learning methods for assessing treatment response after neoadjuvant chemoradiotherapy in patients with locally advanced rectal cancer
  di: Shuang Chen, et al.
  Pubblicazione: (2026)
• Advances in mucosal injury mechanisms in radiation‐induced esophagitis associated with thoracic radiotherapy
  di: Hao Zhang, et al.
  Pubblicazione: (2026)